Endothelial Glycocalyx Integrity as a Prognostic Key in Sepsis: New Insights from the CLOVERS Trial
- PMID: 40632891
- PMCID: PMC12416306
- DOI: 10.1513/AnnalsATS.202506-692ED
Endothelial Glycocalyx Integrity as a Prognostic Key in Sepsis: New Insights from the CLOVERS Trial
Comment on
-
Endothelial Glycocalyx Degradation in Sepsis: Analysis of the Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS) Trial, a Multicenter, Phase 3, Randomized Trial.Ann Am Thorac Soc. 2025 Sep;22(9):1382-1393. doi: 10.1513/AnnalsATS.202501-012OC. Ann Am Thorac Soc. 2025. PMID: 40315385 Clinical Trial.
References
-
- Arina P, Hofmaenner DA, Singer M. Definition and epidemiology of sepsis. Semin Respir Crit Care Med . 2024;45:461–468. - PubMed
-
- Gomez Toledo A, Golden GJ, Cummings RD, Malmström J, Esko JD. Endothelial glycocalyx turnover in vascular health and disease: rethinking endothelial dysfunction. Annu Rev Biochem . 2025;94:561–586. - PubMed
-
- Nelson A, Berkestedt I, Bodelsson M. Circulating glycosaminoglycan species in septic shock. Acta Anaesthesiol Scand . 2014;58:36–43. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
